Status:
COMPLETED
Care Coordination and Proactive Care to Improve Utilization of Resources and Reduce Expenditure in High Risk Inflammatory Bowel Disease (IBD) Patients
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
Twine Clinical Consulting LLC
Conditions:
Inflammatory Bowel Diseases
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The study team performed a randomized controlled trial to evaluate the efficacy of a care coordination intervention composed of proactive symptom monitoring and algorithm-based triggers to improve pat...
Eligibility Criteria
Inclusion
- established diagnosis of IBD (with at least 3 office visits)
- followed in GI clinic within 1 year of enrollment
- in top 20th percentile of predicted risk for subsequent healthcare utilization (previously validated model)
Exclusion
- non-IBD driver for high utilization (e.g., active cancer undergoing treatment
- A life expectancy of less than one year, were excluded from participation.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
425 Patients enrolled
Trial Details
Trial ID
NCT04796571
Start Date
January 1 2019
End Date
March 1 2020
Last Update
March 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48103